# A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

> **NCT06671483** · PHASE3 · RECRUITING · sponsor: **Takeda** · enrollment: 1088 (estimated)

## Conditions studied

- Psoriatic Arthritis

## Interventions

- **DRUG:** Zasocitinib
- **DRUG:** Active Comparator
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06671483
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-03
- **Primary completion:** 2027-05-18
- **Final completion:** 2028-01-28
- **Target enrollment:** 1088 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06671483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06671483, "A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06671483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
